Based on this, Maria Stella Sasso et al. used lethally irradiated tumor cells, overexpressing VEGF‐C to create a lymphangiogenic vaccine which drove the immune response system in mouse melanoma models and identified new prospects for antitumor vaccines.80 Here, VEGFC is linked to neoplasm.